United States Eleventh Circuit

In a False Claims Act action claiming that defendant engaged in an off-label marketing campaign to increase sales of Marinol, a synthetic form of THC, for purposes not approved by the Food and Drug Administration (FDA), dismissal of the complaint is affirmed where the court was unable to discern from the complaint a specific person or entity that was alleged to have presented a claim of any kind, let alone a false or fraudulent claim.

Appellate Information

• Decided 12/07/2009
• Published 12/07/2009

Judges

Court

• United States Eleventh Circuit

Counsel